Keebeck Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.57M Sell
24,608
-548
-2% -$102K 0.6% 46
2025
Q1
$5.27M Buy
25,156
+148
+0.6% +$31K 0.78% 34
2024
Q4
$4.44M Sell
25,008
-141
-0.6% -$25.1K 0.64% 44
2024
Q3
$4.97M Sell
25,149
-234
-0.9% -$46.2K 0.72% 40
2024
Q2
$4.35M Buy
25,383
+8,711
+52% +$1.49M 0.64% 41
2024
Q1
$3.04M Buy
16,672
+13,380
+406% +$2.44M 0.45% 63
2023
Q4
$510K Buy
3,292
+77
+2% +$11.9K 0.08% 174
2023
Q3
$479K Buy
3,215
+168
+6% +$25K 0.08% 177
2023
Q2
$411K Buy
3,047
+35
+1% +$4.72K 0.06% 193
2023
Q1
$480K Sell
3,012
-716
-19% -$114K 0.08% 165
2022
Q4
$602K Buy
3,728
+22
+0.6% +$3.56K 0.11% 140
2022
Q3
$497K Buy
3,706
+8
+0.2% +$1.07K 0.1% 150
2022
Q2
$566K Buy
3,698
+7
+0.2% +$1.07K 0.11% 146
2022
Q1
$598K Buy
3,691
+8
+0.2% +$1.3K 0.1% 150
2021
Q4
$499K Buy
3,683
+312
+9% +$42.3K 0.09% 149
2021
Q3
$364K Buy
3,371
+8
+0.2% +$864 0.07% 160
2021
Q2
$379K Sell
3,363
-16,896
-83% -$1.9M 0.05% 188
2021
Q1
$2.19M Sell
20,259
-114
-0.6% -$12.3K 0.34% 59
2020
Q4
$2.18M Buy
20,373
+11
+0.1% +$1.18K 0.38% 55
2020
Q3
$1.78M Buy
20,362
+904
+5% +$79.2K 0.37% 54
2020
Q2
$1.91M Buy
+19,458
New +$1.91M 0.6% 38
2020
Q1
Sell
-2,458
Closed -$217K 140
2019
Q4
$217K Buy
+2,458
New +$217K 0.07% 136